HomeCompareVASGX vs ORCC

VASGX vs ORCC: Dividend Comparison 2026

VASGX yields 4.15% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VASGX wins by $4.8K in total portfolio value· pulled ahead in Year 2
10 years
VASGX
VASGX
● Live price
4.15%
Share price
$50.07
Annual div
$2.08
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.2K
Annual income
$541.40
Full VASGX calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — VASGX vs ORCC

📍 VASGX pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVASGXORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VASGX + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VASGX pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VASGX
Annual income on $10K today (after 15% tax)
$352.64/yr
After 10yr DRIP, annual income (after tax)
$460.19/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, VASGX beats the other by $459.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VASGX + ORCC for your $10,000?

VASGX: 50%ORCC: 50%
100% ORCC50/50100% VASGX
Portfolio after 10yr
$23.8K
Annual income
$271.22/yr
Blended yield
1.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

VASGX
No analyst data
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VASGX buys
0
ORCC buys
18
PoliticianChamberTickerTypeAmountDate
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-23
Trey Hollingsworth🏢 House$ORCC▲ Buy$250,001 - $500,0002022-06-16
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-14
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-13
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-10
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-09
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-08
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-03
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-05-24
Trey Hollingsworth🏢 House$ORCC▲ Buy$100,001 - $250,0002022-05-20
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVASGXORCC
Forward yield4.15%9.79%
Annual dividend / share$2.08$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$26.2K$21.4K
Annual income after 10y$541.40$1.04
Total dividends collected$4.8K$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: VASGX vs ORCC ($10,000, DRIP)

YearVASGX PortfolioVASGX Income/yrORCC PortfolioORCC Income/yrGap
1$11,115$414.87$11,190$489.61$75.00ORCC
2← crossover$12,324$430.95$12,229$256.01+$95.00VASGX
3$13,633$446.57$13,216$130.74+$417.00VASGX
4$15,049$461.69$14,207$66.02+$842.00VASGX
5$16,579$476.31$15,234$33.17+$1.3KVASGX
6$18,230$490.40$16,317$16.62+$1.9KVASGX
7$20,010$503.95$17,468$8.32+$2.5KVASGX
8$21,927$516.97$18,695$4.16+$3.2KVASGX
9$23,992$529.46$20,006$2.08+$4.0KVASGX
10$26,213$541.40$21,407$1.04+$4.8KVASGX

VASGX vs ORCC: Complete Analysis 2026

VASGXStock

The LifeStrategy Funds are a series of broadly diversified, low-cost funds with an all-index, fixed allocation approach that may provide a complete portfolio in a single fund. The four funds, each with a different allocation, target various risk-based objectives. The Growth Fund seeks to provide capital appreciation and some current income. The fund holds 80% of its assets in stocks, a portion of which is allocated to international stocks, and 20% in bonds, a portion of which is allocated to international bonds. In addition to stock market risk, the fund is also subject to currency risk and country risks. Investors with a long-term time horizon who are looking for growth of principal over time and who can accept stock market volatility may wish to consider this fund.Please note: The Lifestrategy funds are subject to the risks of their underlying funds.Effective May 12, 2026, the fund’s name will change from the Vanguard LifeStrategy Growth Fund to the Vanguard LifeStrategy 80/20 Fund. The fund's investment objective, strategies, and policies will remain unchanged.

Full VASGX Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this VASGX vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VASGX vs SCHDVASGX vs JEPIVASGX vs OVASGX vs KOVASGX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.